Showing results (2141-2150 of 5,535) with videos related to

Sort By:
Pageof 554
Inflammatory Bowel Diseases|February 18, 2020
NOX1 Regulates Collective and Planktonic Cell Migration: Insights From Patients With Pediatric-Onset IBD and NOX1 DeficiencyRazieh Khoshnevisan, Michael Anderson, Stephen Babcock, et al.
Inflammatory Bowel Diseases|February 26, 2020
Circulating Leptin Levels as a Potential Biomarker in Inflammatory Bowel Diseases: A Systematic Review and Meta-AnalysisLarissa Gabriela Ferreira de Carvalho, William Gustavo Lima, Luiz Gonzaga Vaz Coelho, et al.
Inflammatory Bowel Diseases|February 26, 2020
Mental Health Costs of Inflammatory Bowel DiseasesEva Szigethy, Sean M Murphy, Orna G Ehrlich, et al.
Inflammatory Bowel Diseases|June 17, 2021
Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD StudyJurij Hanzel, Erwin Dreesen, Séverine Vermeire, et al.
Inflammatory Bowel Diseases|January 15, 2014
Association between 6-thioguanine nucleotides levels and clinical remission in inflammatory disease: a meta-analysisAmelie Carla Moreau, Stephane Paul, Emilie Del Tedesco, et al.
Inflammatory Bowel Diseases|June 4, 2014
Impaired innate immune function associated with fecal supernatant from Crohn's disease patients: insights into potential pathogenic role of the microbiomeParool Meelu, Romela Marin, Clary Clish, et al.
Inflammatory Bowel Diseases|February 28, 2015
Exercise decreases risk of future active disease in patients with inflammatory bowel disease in remissionPatricia D Jones, Michael D Kappelman, Christopher F Martin, et al.
Inflammatory Bowel Diseases|March 5, 2015
Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remissionJames D Falvey, Teagan Hoskin, Berrie Meijer, et al.
Inflammatory Bowel Diseases|March 5, 2015
Factors associated with mucosal healing in patients with ulcerative colitis in clinical remissionHai Yun Shi, Francis K L Chan, Steven W C Tsang, et al.
Inflammatory Bowel Diseases|April 10, 2015
Efficacy and Safety of Natalizumab and Vedolizumab for the Management of Crohn's Disease: A Systematic Review and Meta-analysisApoorva K Chandar, Siddharth Singh, Mohammad Hassan Murad, et al.
Pageof 554